Publications

2-(2-(2,4-Dioxopentan-3-Ylidene)Hydrazineyl)Benzonitrile as Novel Inhibitor of Receptor Tyrosine Kinase and Pi3K/Akt/Mtor Signaling Pathway in Glioblastoma

AuthID
P-00Q-BNS

Author(s)

Viswanathan, A

Kute, D

Musa, A

Mani, SK

Emmert Streib, F

Yli Harja, O

Document Type

Article

Year published

2019

Published

in EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, ISSN: 0223-5234

Volume: 166, Pages: 291-303 (13)

Indexing

Wos^®

Google Scholar^®

Publication Identifiers

DOI: 10.1016/j.ejmech.2019.01.021

Wos: WOS:000461402400026

Source Identifiers

ISSN: 0223-5234

Export Publication Metadata

Marked List

Add to Marked List

Citations

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference

No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text

Full Text @ sfx.b-on.pt

2-(2-(2,4-Dioxopentan-3-Ylidene)Hydrazineyl)Benzonitrile as Novel Inhibitor of Receptor Tyrosine Kinase and Pi3K/Akt/Mtor Signaling Pathway in Glioblastoma

Useful Links

Get Help

Federated Authentication (Click on the image)

2-(2-(2,4-Dioxopentan-3-Ylidene)Hydrazineyl)Benzonitrile as Novel Inhibitor of Receptor Tyrosine Kinase and Pi3K/Akt/Mtor Signaling Pathway in Glioblastoma

Useful Links

Get Help